RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Smith & Nephew Stock

Smith & Nephew Net Income 2024

Smith & Nephew Net Income

859.36 M USD

Ticker

SN.L

ISIN

GB0009223206

WKN

502816

In 2024, Smith & Nephew's profit amounted to 859.36 M USD, a 226.75% increase from the 263 M USD profit recorded in the previous year.

The Smith & Nephew Net Income history

YEARNET INCOME (undefined USD)
2029e-
2028e1.19
2027e1.09
2026e1.09
2025e1.03
2024e0.86
20230.26
20220.22
20210.52
20200.45
20190.6
20180.66
20170.77
20160.78
20150.41
20140.5
20130.56
20120.73
20110.58
20100.62
20090.47
20080.38
20070.32
20060.75
20050.34
20040.23

Smith & Nephew Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Smith & Nephew, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Smith & Nephew from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Smith & Nephew’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Smith & Nephew. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Smith & Nephew’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Smith & Nephew’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Smith & Nephew’s growth potential.

Smith & Nephew Revenue, EBIT and net profit per share

DateSmith & Nephew RevenueSmith & Nephew EBITSmith & Nephew Net Income
2029e7.95 B undefined0 undefined0 undefined
2028e7.31 B undefined1.6 B undefined1.19 B undefined
2027e6.92 B undefined1.48 B undefined1.09 B undefined
2026e6.57 B undefined1.21 B undefined1.09 B undefined
2025e6.26 B undefined1.12 B undefined1.03 B undefined
2024e5.93 B undefined954.78 M undefined859.36 M undefined
20235.55 B undefined732 M undefined263 M undefined
20225.22 B undefined638 M undefined223 M undefined
20215.21 B undefined720 M undefined524 M undefined
20204.56 B undefined512 M undefined448 M undefined
20195.14 B undefined1.03 B undefined600 M undefined
20184.9 B undefined1.01 B undefined663 M undefined
20174.77 B undefined918 M undefined767 M undefined
20164.67 B undefined890 M undefined784 M undefined
20154.63 B undefined895 M undefined410 M undefined
20144.62 B undefined965 M undefined501 M undefined
20134.35 B undefined899 M undefined556 M undefined
20124.14 B undefined846 M undefined729 M undefined
20114.27 B undefined862 M undefined582 M undefined
20103.96 B undefined935 M undefined615 M undefined
20093.77 B undefined796 M undefined472 M undefined
20083.8 B undefined698 M undefined377 M undefined
20073.37 B undefined565 M undefined316 M undefined
20062.78 B undefined537 M undefined745 M undefined
20052.56 B undefined516.2 M undefined339.9 M undefined
20042.29 B undefined423.1 M undefined229.3 M undefined

Smith & Nephew stock margins

The Smith & Nephew margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Smith & Nephew. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Smith & Nephew.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Smith & Nephew's sales revenue. A higher gross margin percentage indicates that the Smith & Nephew retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Smith & Nephew's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Smith & Nephew's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Smith & Nephew's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Smith & Nephew. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Smith & Nephew's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Smith & Nephew Margin History

Smith & Nephew Gross marginSmith & Nephew Profit marginSmith & Nephew EBIT marginSmith & Nephew Profit margin
2029e70.68 %0 %0 %
2028e70.68 %21.89 %16.3 %
2027e70.68 %21.37 %15.69 %
2026e70.68 %18.39 %16.61 %
2025e70.68 %17.87 %16.43 %
2024e70.68 %16.09 %14.48 %
202370.68 %13.19 %4.74 %
202271.05 %12.23 %4.28 %
202171.09 %13.81 %10.05 %
202069.85 %11.23 %9.82 %
201974.19 %19.97 %11.68 %
201873.61 %20.6 %13.52 %
201773.81 %19.27 %16.1 %
201672.76 %19.06 %16.79 %
201575.33 %19.31 %8.85 %
201475.59 %20.9 %10.85 %
201375.11 %20.66 %12.78 %
201274.14 %20.45 %17.62 %
201173.3 %20.19 %13.63 %
201073.98 %23.6 %15.52 %
200972.69 %21.1 %12.51 %
200871.67 %18.36 %9.92 %
200770.5 %16.77 %9.38 %
200672.33 %19.32 %26.81 %
200574.34 %20.19 %13.29 %
200473.18 %18.5 %10.03 %

Smith & Nephew Aktienanalyse

What does Smith & Nephew do?

Smith & Nephew PLC was founded in 1856 by Thomas James Smith in Hull, United Kingdom, as a manufacturer of bandages and orthopedic products. The company has since evolved into a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company is divided into three business segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The product range includes a wide range of products used for the treatment of injuries and diseases. This includes artificial joints, instruments for minimally invasive surgery, as well as wound care products such as dressings, compression stockings, and pain therapy systems. The Orthopaedics business segment offers a wide range of products for the treatment of arthritis, joint injuries, and other orthopedic conditions. This includes artificial joints, knee and hip prostheses, and implants for bone fracture stabilization. The company was one of the first to develop an artificial joint prosthesis and has since played a leading role in this field. The Endoscopy business segment provides instruments for minimally invasive surgery. These devices allow surgeons to perform less invasive surgical procedures that allow for faster patient recovery. The product range includes endoscopes, probes, and other instruments used for surgeries in the abdominal cavity, thoracic cavity, joints, and other areas of the body. Smith & Nephew's Advanced Wound Management business segment offers products for effective wound treatment. This includes wound dressings, compression stockings, shoes, and pain therapy systems. These products help reduce healing time and decrease the likelihood of infections. Smith & Nephew is headquartered in London, United Kingdom, and employs over 17,500 people worldwide. The company operates in more than 100 countries and has manufacturing facilities in Europe, Asia, and North America. In 2020, Smith & Nephew's revenue amounted to $4.6 billion. The business model of Smith & Nephew is based on innovation and the development of new technologies. The company invests a significant portion of its revenue each year in research and development to expand and improve its product range. Additionally, the company works closely with doctors and hospitals to better understand patient needs and offer tailored solutions. In recent years, Smith & Nephew has also invested in digital health. The company utilizes innovative technologies such as artificial intelligence and cloud solutions to provide better care and support to patients. This includes the introduction of mobile apps that assist patients in monitoring and self-treating their conditions. In conclusion, Smith & Nephew is a globally operating healthcare company specializing in the manufacturing and distribution of medical devices. The company has a wide product range used for the treatment of injuries and diseases. Its business model is based on innovation and the development of new technologies. Close collaboration with doctors and hospitals, as well as the utilization of digital technologies, are important pillars of the company. Smith & Nephew ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Smith & Nephew's Profit Margins

The profit margins of Smith & Nephew represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Smith & Nephew's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Smith & Nephew's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Smith & Nephew's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Smith & Nephew’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Smith & Nephew stock

How much profit has Smith & Nephew made this year?

Smith & Nephew has made 859.36 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 226.75% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Smith & Nephew publish its earnings?

Smith & Nephew publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Smith & Nephew?

The profits of Smith & Nephew are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Smith & Nephew?

You can learn more about the earnings of Smith & Nephew by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Smith & Nephew pay?

Over the past 12 months, Smith & Nephew paid a dividend of 0.3 USD . This corresponds to a dividend yield of about 1.95 %. For the coming 12 months, Smith & Nephew is expected to pay a dividend of 0.3 USD.

What is the dividend yield of Smith & Nephew?

The current dividend yield of Smith & Nephew is 1.95 %.

When does Smith & Nephew pay dividends?

Smith & Nephew pays a quarterly dividend. This is distributed in the months of November, April, May, November.

How secure is the dividend of Smith & Nephew?

Smith & Nephew paid dividends every year for the past 0 years.

What is the dividend of Smith & Nephew?

For the upcoming 12 months, dividends amounting to 0.3 USD are expected. This corresponds to a dividend yield of 1.96 %.

In which sector is Smith & Nephew located?

Smith & Nephew is assigned to the 'Health' sector.

Wann musste ich die Aktien von Smith & Nephew kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Smith & Nephew from 11/8/2024 amounting to 0.144 USD, you needed to have the stock in your portfolio before the ex-date on 10/3/2024.

When did Smith & Nephew pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Smith & Nephew in the year 2023?

In the year 2023, Smith & Nephew distributed 0.313 USD as dividends.

In which currency does Smith & Nephew pay out the dividend?

The dividends of Smith & Nephew are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Smith & Nephew stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Smith & Nephew

Our stock analysis for Smith & Nephew Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Smith & Nephew Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.